T1	Participants 129 140	young males
T2	Participants 370 418	young males with hereditary androgenic alopecia.
T3	Participants 553 685	20 subjects who received two tablets of ViviScal once daily and 20 who received two tablets of fish extract once daily for 6 months.
T4	Participants 788 801	Most patients